Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2009
12/30/2009CN101616918A 4-(pyrrolopyridinyl)pyrimidin-2-ylamine derivatives
12/30/2009CN101616917A Pyrido [2, 3-d] pyrimidines and their use as kinase inhibitors
12/30/2009CN101613350A Chiral compound and synthesis method thereof
12/30/2009CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor
12/30/2009CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
12/30/2009CA2728767A1 Alkynyl alcohols as kinase inhibitors
12/30/2009CA2728696A1 Substituted pyrimidin-4-one derivatives
12/30/2009CA2728695A1 Substituted alkyl pyrimidin-4-one derivatives
12/30/2009CA2728694A1 Substituted pyrimidone derivatives
12/30/2009CA2728693A1 Substituted pyrimido [2, 1-a] isoquinolin-4-one derivatives
12/30/2009CA2727455A1 Heteroaryl compounds and uses thereof
12/29/2009US7638629 4-Isopropylphenyl)-2-[4-(trifluoromethyl)phenyl]piperidin-4-yl}acetic acid; modulators of gamma secretase isoforms, 1-42; antifibrillatory agents; neurodegenerative diseases; modulating activity of gamma -secretase as opposed to suppressing it to reduced risk of side effects; beta secretase inhibitors
12/29/2009US7638546 Imidazolyl derivatives
12/29/2009US7638537 Pyrazole compounds as transforming growth factor (TGF) inhibitors
12/29/2009US7638531 use in treating inflammatory diseases, allergic conditions, diabetes, obesity, an obesity-related disorder, metabolic syndrome, a cognition deficit disorder, cardiovascular and central nervous system disorders
12/29/2009US7638530 1-{1-[4-(3-amino-5-phenyl-1H-pyrazolo[3,4-b]pyridin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; anticarcinogenic agents
12/29/2009US7638529 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
12/29/2009US7638527 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction
12/29/2009US7638526 Inflammatory pain, chronic pain, and neuropathic pain; for inhibiting absorption of cholesterol
12/29/2009US7638517 3-Amino-1-arylpropyl azaindoles and uses thereof
12/29/2009US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors
12/29/2009US7638509 Diene compounds and formulations
12/29/2009CA2563761C Inhibitors of the hiv integrase enzyme
12/29/2009CA2524043C 1-(2h-pyrazol-3-yl)-3-{4-'1-(benzoyl)-piperidin-4-ylmethyl!-phenyl}-urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations
12/29/2009CA2478799C Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
12/29/2009CA2447521C Delivery of antihistamines through an inhalation route
12/29/2009CA2429440C Dehalogeno-compounds
12/29/2009CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors
12/29/2009CA2287214C Substituted benzopyran derivatives for the treatment of inflammation
12/24/2009US20090318700 Process for preparing pradofloxacin
12/24/2009US20090318695 Processes for the preparation of varenicline and intermediates thereof
12/24/2009US20090318494 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
12/24/2009US20090318493 Aryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof
12/24/2009US20090318492 Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitors
12/24/2009US20090318491 Cytisine and Acetylcholine Analogs and Methods of Treating Mood Disorders
12/24/2009US20090318490 Compounds and methods for promoting smoking cessation
12/24/2009US20090318486 Tricyclic spiro derivatives as CRTH2 modulators
12/24/2009US20090318472 Aminopyrazine derivatives and compositions
12/24/2009US20090318463 Indolylmaleimide Derivatives
12/24/2009US20090318460 Amorphous varenicline tartrate and process for the preparation thereof
12/24/2009US20090318455 Compounds and methods for treating inflammatory and fibrotic disorders
12/24/2009US20090318445 Pdf inhibitors
12/24/2009US20090318443 Kinase inhibitors
12/24/2009US20090318437 SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE
12/24/2009US20090318436 Fused heterocyclic derivatives and methods of use
12/24/2009US20090318435 Pyrazolopyridines and analogs thereof
12/24/2009US20090318434 Composition and process - 356
12/24/2009US20090318428 Heteroaryl derivatives as protein kinase inhibitors
12/24/2009US20090318421 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
12/24/2009US20090318409 Pyrrolidine inhibitors of iap
12/24/2009US20090318385 Pyrazolopyride derivative and phosphodiesterase ( pde) inhibitors containing the same as active ingredient
12/24/2009US20090318373 Receptor-type kinase modulators and methods of use
12/24/2009US20090317842 Methods and Tools for The Therapy of Neurodegenerative Pathologies
12/24/2009US20090315025 Liquid crystalline organic semiconductor material and organic electron device
12/23/2009WO2009155403A2 Processes for the preparation of varenicline and intermediates thereof
12/23/2009WO2009155389A1 Triazolopyridine compounds useful as kinase inhibitors
12/23/2009WO2009155388A1 Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
12/23/2009WO2009155121A2 Inhibitors of pi3 kinase
12/23/2009WO2009155052A1 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/23/2009WO2009155001A2 Wnt protein signalling inhibitors
12/23/2009WO2009154132A1 Spirodiamine-diarylketoxime derivative
12/23/2009WO2009153721A1 Nicotinamide derivatives
12/23/2009WO2009153597A2 Composition and process - 356
12/23/2009WO2009153516A1 Novel derivatives of pyrroloindole inhibitors of hsp90, compositions containing same, and use thereof
12/23/2009WO2009153182A1 Novel heteroaryl carboxamide derivatives
12/23/2009WO2009152909A1 Quinoxalinedione derivatives
12/23/2009WO2009152824A1 Heterocyclic derivatives as iap binding compounds
12/23/2009WO2009152584A1 Synthesis of ageladine a and analogs thereof
12/23/2009EP2135870A1 Process for production of mirtazapine
12/23/2009EP2134712A1 Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro [3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8] naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same
12/23/2009EP2134710A1 Substituted heterocycle fused gamma-carbolines synthesis
12/23/2009EP2134693A2 Metalloprotease inhibitors containing a heterocyclic moiety
12/23/2009EP2134346A1 Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1
12/23/2009EP2134343A2 Pyrrolo-pyridine kinase modulators
12/23/2009EP2134342A2 Monocyclic anilide spirolactam cgrp receptor antagonists
12/23/2009EP1879564B1 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
12/23/2009EP1709037B1 Hiv protease inhibiting sulfonamides
12/23/2009EP1682550B1 Substituted naphthyridinone derivatives
12/23/2009EP1296972B1 Arylmethylamine derivatives for use as tryptase inhibitors
12/23/2009CN101611034A New triazabenzo[a]naphtho[2,l,8-cde]azulene derivatives, method for preparing the same and pharmaceutical compositions containing the same
12/23/2009CN101611025A 5,6-ring annulated indole derivatives and methods of use thereof
12/23/2009CN101611014A Acylaminopyrazoles as FGFR inhibitors
12/23/2009CN101611002A 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
12/23/2009CN101607958A Quinazoline compounds
12/23/2009CN100572382C Heterocyclic compound capable of inversing tumor cell drug tolerance, preparation method and application thereof
12/23/2009CN100572381C Pyrazolonaphthyridine derivative
12/23/2009CN100572363C New imidazole derivative, method for producing the same and use of the same
12/23/2009CA2728476A1 Heterocyclic compound and use thereof
12/23/2009CA2728183A1 Compositions with and process for methylmorpholin-substituted pyrido [2,3-d] pryimidines
12/23/2009CA2728018A1 Quinoxalinedione derivatives
12/23/2009CA2727928A1 Inhibitors of janus kinases
12/23/2009CA2727914A1 Spirodiamine-diaryl ketoxime derivative technical field
12/23/2009CA2727626A1 Novel derivatives of pyrroloindole inhibitors of hsp90, compositions containing same, and use thereof
12/23/2009CA2727036A1 Triazolopyridine jak inhibitor compounds and methods
12/23/2009CA2726844A1 Triazolopyridine jak inhibitor compounds and methods
12/23/2009CA2726164A1 Wnt protein signalling inhibitors
12/23/2009CA2725934A1 Novel substituted indoles
12/23/2009CA2725657A1 Novel heteroaryl carboxamide derivatives
12/23/2009CA2725481A1 Nicotinamide derivatives
12/23/2009CA2725014A1 Inhibitors of pi3 kinase
1 ... 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 ... 646